Running title: Optimal Dosing of rhEPO in TKA Patients
Zichuan Ding1, Mingcheng Yuan1,
Qifeng Tao2, Duan Wang1, Haoyang
Wang1,*, Zongke Zhou1,*
1 Department of Orthopedics, West China Hospital/West
China School of Medicine, Sichuan University, 37# Wuhou Guoxue Road,
Chengdu, P.R. China.
2 Department of Orthopedics, Panzhihua Municipal
Central Hospital Panzhihua, Panzhihua, People’s Republic of China.
* Corresponding author: Department of Orthopedics,
West China Hospital/West China School of Medicine, Sichuan University,
37# Wuhou Guoxue Road, Chengdu, P.R. China.
Zichuan Ding and Mingcheng Yuan contributed equally to this work.
Principal investigator statement: The authors confirm that the
principal investigator for this paper is Zongke Zhou and that he had
direct clinical responsibility for patients.
Key words: total knee arthroplasty, recombinant human
erythropoietin, autologous blood donation, dosing schedule